WMJ‐8‐B, a novel hydroxamate derivative, induces MDA‐MB‐231 breast cancer cell death via the SHP‐1‐STAT3‐survivin cascade

Por Chuang, Yu‐Fan, Huang, Shiu‐Wen, Hsu, Ya‐Fen, Yu, Meng‐Chieh, Ou, George, Huang, Wei‐Jan, Hsu, Ming‐Jen
Publicado no Br J Pharmacol (2017)

A Novel Hydroxamate-Based Compound WMJ-J-09 Causes Head and Neck Squamous Cell Carcinoma Cell Death via LKB1-AMPK-p38MAPK-p63-Survivin Cascade

Por Yen, Chia-Sheng, Choy, Cheuk-Sing, Huang, Wei-Jan, Huang, Shiu-Wen, Lai, Pin-Ye, Yu, Meng-Chieh, Shiue, Ching, Hsu, Ya-Fen, Hsu, Ming-Jen
Publicado no Front Pharmacol (2018)

Trichostatin A Suppresses EGFR Expression through Induction of MicroRNA-7 in an HDAC-Independent Manner in Lapatinib-Treated Cells

Por Tu, Chih-Yen, Chen, Chia-Hung, Hsia, Te-Chun, Hsu, Min-Hsiang, Wei, Ya-Ling, Yu, Meng-Chieh, Chen, Wen-Shu, Hsu, Ke-Wei, Yeh, Ming-Hsin, Liu, Liang-Chih, Chen, Yun-Ju, Huang, Wei-Chien
Publicado em 2014

Lapatinib–induced NF-kappaB activation sensitizes triple-negative breast cancer cells to proteasome inhibitors

Por Chen, Yun-Ju, Yeh, Ming-Hsin, Yu, Meng-Chieh, Wei, Ya-Ling, Chen, Wen-Shu, Chen, Jhen-Yu, Shih, Chih-Yu, Tu, Chih-Yen, Chen, Chia-Hung, Hsia, Te-Chun, Chien, Pei-Hsuan, Liu, Shu-Hui, Yu, Yung-Luen, Huang, Wei-Chien
Publicado em 2013